Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Reversal of epigenetic aging and immunosenescent trends in humans.

Fahy GM, Brooke RT, Watson JP, Good Z, Vasanawala SS, Maecker H, Leipold MD, Lin DTS, Kobor MS, Horvath S.

Aging Cell. 2019 Sep 8:e13028. doi: 10.1111/acel.13028. [Epub ahead of print]

2.

Getting the Most from Your High-Dimensional Cytometry Data.

Olsen LR, Pedersen CB, Leipold MD, Maecker HT.

Immunity. 2019 Mar 19;50(3):535-536. doi: 10.1016/j.immuni.2019.02.015. No abstract available.

PMID:
30893579
3.

A clinically meaningful metric of immune age derived from high-dimensional longitudinal monitoring.

Alpert A, Pickman Y, Leipold M, Rosenberg-Hasson Y, Ji X, Gaujoux R, Rabani H, Starosvetsky E, Kveler K, Schaffert S, Furman D, Caspi O, Rosenschein U, Khatri P, Dekker CL, Maecker HT, Davis MM, Shen-Orr SS.

Nat Med. 2019 Mar;25(3):487-495. doi: 10.1038/s41591-019-0381-y. Epub 2019 Mar 6.

4.

The anatomy of single cell mass cytometry data.

Olsen LR, Leipold MD, Pedersen CB, Maecker HT.

Cytometry A. 2019 Feb;95(2):156-172. doi: 10.1002/cyto.a.23621. Epub 2018 Oct 2. Review.

PMID:
30277658
5.

Comparison of CyTOF assays across sites: Results of a six-center pilot study.

Leipold MD, Obermoser G, Fenwick C, Kleinstuber K, Rashidi N, McNevin JP, Nau AN, Wagar LE, Rozot V, Davis MM, DeRosa S, Pantaleo G, Scriba TJ, Walker BD, Olsen LR, Maecker HT.

J Immunol Methods. 2018 Feb;453:37-43. doi: 10.1016/j.jim.2017.11.008. Epub 2017 Nov 23.

6.

Guidelines for the use of flow cytometry and cell sorting in immunological studies.

Cossarizza A, Chang HD, Radbruch A, Akdis M, Andrä I, Annunziato F, Bacher P, Barnaba V, Battistini L, Bauer WM, Baumgart S, Becher B, Beisker W, Berek C, Blanco A, Borsellino G, Boulais PE, Brinkman RR, Büscher M, Busch DH, Bushnell TP, Cao X, Cavani A, Chattopadhyay PK, Cheng Q, Chow S, Clerici M, Cooke A, Cosma A, Cosmi L, Cumano A, Dang VD, Davies D, De Biasi S, Del Zotto G, Della Bella S, Dellabona P, Deniz G, Dessing M, Diefenbach A, Di Santo J, Dieli F, Dolf A, Donnenberg VS, Dörner T, Ehrhardt GRA, Endl E, Engel P, Engelhardt B, Esser C, Everts B, Dreher A, Falk CS, Fehniger TA, Filby A, Fillatreau S, Follo M, Förster I, Foster J, Foulds GA, Frenette PS, Galbraith D, Garbi N, García-Godoy MD, Geginat J, Ghoreschi K, Gibellini L, Goettlinger C, Goodyear CS, Gori A, Grogan J, Gross M, Grützkau A, Grummitt D, Hahn J, Hammer Q, Hauser AE, Haviland DL, Hedley D, Herrera G, Herrmann M, Hiepe F, Holland T, Hombrink P, Houston JP, Hoyer BF, Huang B, Hunter CA, Iannone A, Jäck HM, Jávega B, Jonjic S, Juelke K, Jung S, Kaiser T, Kalina T, Keller B, Khan S, Kienhöfer D, Kroneis T, Kunkel D, Kurts C, Kvistborg P, Lannigan J, Lantz O, Larbi A, LeibundGut-Landmann S, Leipold MD, Levings MK, Litwin V, Liu Y, Lohoff M, Lombardi G, Lopez L, Lovett-Racke A, Lubberts E, Ludewig B, Lugli E, Maecker HT, Martrus G, Matarese G, Maueröder C, McGrath M, McInnes I, Mei HE, Melchers F, Melzer S, Mielenz D, Mills K, Mirrer D, Mjösberg J, Moore J, Moran B, Moretta A, Moretta L, Mosmann TR, Müller S, Müller W, Münz C, Multhoff G, Munoz LE, Murphy KM, Nakayama T, Nasi M, Neudörfl C, Nolan J, Nourshargh S, O'Connor JE, Ouyang W, Oxenius A, Palankar R, Panse I, Peterson P, Peth C, Petriz J, Philips D, Pickl W, Piconese S, Pinti M, Pockley AG, Podolska MJ, Pucillo C, Quataert SA, Radstake TRDJ, Rajwa B, Rebhahn JA, Recktenwald D, Remmerswaal EBM, Rezvani K, Rico LG, Robinson JP, Romagnani C, Rubartelli A, Ruckert B, Ruland J, Sakaguchi S, Sala-de-Oyanguren F, Samstag Y, Sanderson S, Sawitzki B, Scheffold A, Schiemann M, Schildberg F, Schimisky E, Schmid SA, Schmitt S, Schober K, Schüler T, Schulz AR, Schumacher T, Scotta C, Shankey TV, Shemer A, Simon AK, Spidlen J, Stall AM, Stark R, Stehle C, Stein M, Steinmetz T, Stockinger H, Takahama Y, Tarnok A, Tian Z, Toldi G, Tornack J, Traggiai E, Trotter J, Ulrich H, van der Braber M, van Lier RAW, Veldhoen M, Vento-Asturias S, Vieira P, Voehringer D, Volk HD, von Volkmann K, Waisman A, Walker R, Ward MD, Warnatz K, Warth S, Watson JV, Watzl C, Wegener L, Wiedemann A, Wienands J, Willimsky G, Wing J, Wurst P, Yu L, Yue A, Zhang Q, Zhao Y, Ziegler S, Zimmermann J.

Eur J Immunol. 2017 Oct;47(10):1584-1797. doi: 10.1002/eji.201646632. No abstract available.

7.

Molecular markers provide evidence for a broad-fronted recolonisation of the widespread calcareous grassland species Sanguisorba minor from southern and cryptic northern refugia.

Tausch S, Leipold M, Poschlod P, Reisch C.

Plant Biol (Stuttg). 2017 Jul;19(4):562-570. doi: 10.1111/plb.12570. Epub 2017 May 2.

PMID:
28387987
8.
9.

Multiparameter Phenotyping of Human PBMCs Using Mass Cytometry.

Leipold MD, Newell EW, Maecker HT.

Methods Mol Biol. 2015;1343:81-95. doi: 10.1007/978-1-4939-2963-4_7.

10.

Platinum-conjugated antibodies for application in mass cytometry.

Mei HE, Leipold MD, Maecker HT.

Cytometry A. 2016 Mar;89(3):292-300. doi: 10.1002/cyto.a.22778. Epub 2015 Sep 10.

11.

Computationally efficient multidimensional analysis of complex flow cytometry data using second order polynomial histograms.

Zaunders J, Jing J, Leipold M, Maecker H, Kelleher AD, Koch I.

Cytometry A. 2016 Jan;89(1):44-58. doi: 10.1002/cyto.a.22704. Epub 2015 Jun 11.

12.

Another step on the path to mass cytometry standardization.

Leipold MD.

Cytometry A. 2015 May;87(5):380-2. doi: 10.1002/cyto.a.22661. Epub 2015 Apr 9. No abstract available.

13.

Barcoding of live human peripheral blood mononuclear cells for multiplexed mass cytometry.

Mei HE, Leipold MD, Schulz AR, Chester C, Maecker HT.

J Immunol. 2015 Feb 15;194(4):2022-31. doi: 10.4049/jimmunol.1402661. Epub 2015 Jan 21.

14.

Phenotyping of Live Human PBMC using CyTOF™ Mass Cytometry.

Leipold MD, Maecker HT.

Bio Protoc. 2015;5(2). pii: e1382. Epub 2015 Jan 20.

15.

The Split Virus Influenza Vaccine rapidly activates immune cells through Fcγ receptors.

O'Gorman WE, Huang H, Wei YL, Davis KL, Leipold MD, Bendall SC, Kidd BA, Dekker CL, Maecker HT, Chien YH, Davis MM.

Vaccine. 2014 Oct 14;32(45):5989-97. doi: 10.1016/j.vaccine.2014.07.115. Epub 2014 Sep 6.

16.

Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry.

Horowitz A, Strauss-Albee DM, Leipold M, Kubo J, Nemat-Gorgani N, Dogan OC, Dekker CL, Mackey S, Maecker H, Swan GE, Davis MM, Norman PJ, Guethlein LA, Desai M, Parham P, Blish CA.

Sci Transl Med. 2013 Oct 23;5(208):208ra145. doi: 10.1126/scitranslmed.3006702.

17.

Mass cytometry: protocol for daily tuning and running cell samples on a CyTOF mass cytometer.

Leipold MD, Maecker HT.

J Vis Exp. 2012 Nov 2;(69):e4398. doi: 10.3791/4398.

18.

Development of mass cytometry methods for bacterial discrimination.

Leipold MD, Ornatsky O, Baranov V, Whitfield C, Nitz M.

Anal Biochem. 2011 Dec 1;419(1):1-8. doi: 10.1016/j.ab.2011.07.035. Epub 2011 Aug 5.

PMID:
21871432
19.

ICP-MS-based multiplex profiling of glycoproteins using lectins conjugated to lanthanide-chelating polymers.

Leipold MD, Herrera I, Ornatsky O, Baranov V, Nitz M.

J Proteome Res. 2009 Feb;8(2):443-9. doi: 10.1021/pr800645r.

21.

The C-terminal Domain of the Escherichia coli WaaJ glycosyltransferase is important for catalytic activity and membrane association.

Leipold MD, Kaniuk NA, Whitfield C.

J Biol Chem. 2007 Jan 12;282(2):1257-64. Epub 2006 Nov 7.

22.

Recognition and removal of oxidized guanines in duplex DNA by the base excision repair enzymes hOGG1, yOGG1, and yOGG2.

Leipold MD, Workman H, Muller JG, Burrows CJ, David SS.

Biochemistry. 2003 Sep 30;42(38):11373-81.

PMID:
14503888
23.

Structure and potential mutagenicity of new hydantoin products from guanosine and 8-oxo-7,8-dihydroguanine oxidation by transition metals.

Burrows CJ, Muller JG, Kornyushyna O, Luo W, Duarte V, Leipold MD, David SS.

Environ Health Perspect. 2002 Oct;110 Suppl 5:713-7. Review.

24.

Removal of hydantoin products of 8-oxoguanine oxidation by the Escherichia coli DNA repair enzyme, FPG.

Leipold MD, Muller JG, Burrows CJ, David SS.

Biochemistry. 2000 Dec 5;39(48):14984-92.

PMID:
11101315
25.

[Anesthesia problems in hearing improvement operations].

LEIPOLD M.

Z Laryngol Rhinol Otol. 1960 Jul;39:429-32. German. No abstract available.

PMID:
13760581
26.

[Reticuloses in otorhinolaryngology].

LEIPOLD M.

HNO. 1960 Jan 25;8:123-7. German. No abstract available.

PMID:
14415469
27.

[Pharmacological hibernation in intracranial complications].

LEIPOLD M.

Arch Ohren Nasen Kehlkopfheilkd. 1960;176:781-4. German. No abstract available.

PMID:
13760582
28.

[Clinical experience with the local anesthetic hostacain in otorhinolaryngology].

LEIPOLD M.

Anaesthesist. 1959 May;8(5):137-9. German. No abstract available.

PMID:
13670429
29.

[On anesthesia in tumor surgery of the nasopharynx].

LEIPOLD M.

Arch Ohren Nasen Kehlkopfheilkd. 1959;175:292-6. German. No abstract available.

PMID:
14415468
30.

[Pathology & clinical manifestations of glossal hemangiomas with special reference to their therapy].

LEIPOLD M.

Z Laryngol Rhinol Otol. 1958 May;37(5):307-12. German. No abstract available.

PMID:
13570232

Supplemental Content

Loading ...
Support Center